cBAT - CBAT

Ultime notizie per CBAK Energy Tech (NASDAQ:CBAT) Azioni

CBAK Energy Tech

CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.

CBAK Energy Technology, Inc. - Common Stock

CBAK Energy Technology Inc

Evotec SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVO#NASDAQ">EVO</a>) shares are trading higher in the <a href="https://www.benzinga.com/movers">premarket session on Wednesday</a>. This surge follows the company&#8217;s announcement that it has joined the NURTuRE-AKI consortium.
NURTuRE-AKI consortium is a collaboration aimed at developing an extensive patient database for acute kidney injury (AKI) <a href="https://www.benzinga.com/pressreleases/25/06/ac46087889/evotec-joins-nurture-aki-consortium-to-gain-multi-omics-based-molecular-understanding-of-acute-ki" target="_blank" rel="noreferrer noopener">research and therapeutic discovery</a>.
The initiative, known as NURTuRE-AKI, will help Evotec identify core biological mechanisms behind AKI and propel the discovery of novel treatment options.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44720573/kidney-disease-focused-vera-therapeutics-concludes-enrollment-in-pivotal-study-targets-2026-commercial-launch" rel="noreferrer noopener">Kidney Disease-Focused Vera Therapeutics Concludes Enrollment In Pivotal Study, Targets 2026 Commercial Launch</a>
Evotec will integrate this data into its E.MPD platform, a molecular-level database that consolidates clinical and omics information, to enhance precision medicine capabilities.
By collecting longitudinal data across multiple stages of patient treatment, researchers will be able to evaluate disease progression with unprecedented depth and accuracy.
NURTuRE-AKI will focus on patients most vulnerable to AKI, including those undergoing cardiac surgery and individuals transitioning from acute kidney injury to chronic kidney disease.
The project will gather samples of blood, urine, DNA, and tissue alongside medical data, forming what is expected to be the most comprehensive AKI cohort worldwide.
&#8220;NURTuRE-AKI offers a rare opportunity to uncover molecular targets and develop biomarkers that could accelerate breakthroughs in kidney care,&#8221; said Cord Dohrmann, Chief Scientific Officer of Evotec.
He emphasized the company&#8217;s commitment to finding collaborators aligned with this mission.
Elaine Davies, Director of Research Operations at Kidney Research U.K., expressed optimism about the partnership, noting the initiative&#8217;s potential to reshape how kidney diseases are diagnosed and treated.
Price Action: EVO shares are trading higher by 3.19% to $4.210 premarket at last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/partner/general/25/06/46057355/p3-reveals-how-data-is-solving-the-healthcare-crisis-for-seniors" target="_blank" rel="noreferrer noopener">P3 Reveals How Data Is Solving The Healthcare Crisis For Seniors</a></li>
</ul>
Photo via Shutterstock

Biotech

Equities

News

Health Care

Markets

Movers

General

Evotec's Collaboration Sparks Hope For Acute Kidney Injury Breakthroughs

The U.S. government has successfully tested a long-range radar detection system that could be utilized in President Donald Trump's ambitious <a href="https://www.benzinga.com/25/05/45548110/trumps-golden-dome-launches-new-era-for-defense-stocks-like-rtx-lockheed-martin-l3harris">Golden Dome missile defense system</a>.
What Happened: The Long Range Discrimination Radar, built by defense giant Lockheed Martin Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>), successfully acquired, tracked and reported missile data during a test in Alaska's Clear Space Force Station, Reuters reported on Tuesday.
The report suggests that the LRDR is currently placed as part of the Ground-Based Midcourse Defense, designed to increase the efficacy of interceptors for missiles fired on the country by Iran or North Korea.
The system successfully tracked a target developed by the U.S. Missile Defense Agency over 1243 miles or 2,000 kilometers off the coast of Alaska, the report shared.
Why It Matters: The radar system could play a crucial role in Trump's Golden Dome, which will reportedly cost over $175 billion to develop, has already attracted a lot of attention from defense as well as tech companies.
SpaceX, as well as Peter Thiel's Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), have both reportedly <a href="https://www.benzinga.com/25/04/44861620/spacex-palantir-frontrunners-in-bid-that-could-build-donald-trumps-golden-dome-report">emerged as ‘frontrunners'</a> to secure key contracts within the initiative.
However, other companies like Lockheed Martin as well as Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) have also <a href="https://www.benzinga.com/markets/equities/25/06/45973965/boeing-lockheed-martin-compete-for-key-role-in-trumps-175-billion-golden-dome-project">joined the race </a>with Lockheed Martin CEO Tim Cahill saying that the company has "a whole number of product lines that will contribute very well, that are going to fit very well with what is necessary to achieve the mission."
Despite the developments, many have expressed serious concerns about the system's development and some experts believe the initiative could trigger a worldwide <a href="https://www.benzinga.com/general/space/25/05/45584539/donald-trumps-175-billion-golden-dome-could-trigger-a-new-space-arms-race-expert-warns-its-opening-a-pandoras-box">space-based arms race</a>.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45548110/trumps-golden-dome-launches-new-era-for-defense-stocks-like-rtx-lockheed-martin-l3harris">Trump&#8217;s Expensive Golden Dome Launches New Era For Defense Stocks Like RTX, Lockheed Martin, L3Harris</a></li>
</ul>
Image Via Shutterstock

PLTR

US Tests Radar That Could Help Trump's Golden Dome Detect Missiles Over 1,200 Miles: Report

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Aclaris Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACRS#NASDAQ">ACRS</a>) with a Buy and maintains $16 price target.

Price Target

Reiteration

Analyst Ratings

ACRS

HC Wainwright & Co. Reiterates Buy on Aclaris Therapeutics, Maintains $16 Price Target

Artificial intelligence startup, BigBear.ai Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>), has witnessed big spikes in recent weeks, as retail investors seize on rising short interest and swelling options activity to fuel speculations of a short squeeze.
Check out the current price of <a href="https://benzinga.com/quote/BBAI">BBAI stock here</a>.
What Happened: On Tuesday, shares of <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46080056/bigbear-ai-bbai-stock-soars-21-whats-going-on">BigBear rallied 25.12%</a>, ending the day at $5.23 per share, as the company announced a string of strategic partnerships and deployments over the past couple of days.
This includes its <a href="https://www.benzinga.com/pressreleases/25/06/b45972242/bigbear-ai-deploys-enhanced-passenger-processing-biometric-technology-at-major-ports-of-entry-incl">biometric ID software</a> going live across major U.S. and international airports, including JFK, LAX, and Chicago O'Hare, according to an announcement made last week. Before this, the company inked a strategic partnership with Easy Lease PJSC to accelerate its AI development and deployment in the Middle East.
BigBear has also had two major Department of Defense wins in 2025, a J-35 force management contract and a geopolitical risk prototype with the DoD&#8217;s Chief Digital and Artificial Intelligence Office.
See Also: <a href="https://www.benzinga.com/markets/equities/25/06/46089114/google-built-android-to-protect-its-ad-empire-not-ai-says-perplexitys-aravind-srinivas-says-os-must-be-reengineered-for-agentic-future">Google Built Android To Protect Its Ad Empire, Not AI, Says Perplexity&#8217;s Aravind Srinivas: Says OS Must Be Reengineered For Agentic Future</a>
All of these were key catalysts for the company, which many analysts have since dubbed &#8220;The Next Palantir,&#8221; given the remarkable similarities in their areas of focus.
However, the key reason behind recent spikes in the stock is its elevated short interest, with 22.25% <a href="https://fintel.io/ss/us/bbai">of</a> the company&#8217;s float, or approximately 65 million shares, being sold short. This is paired with a borrow fee of 4.69%, up from 3.23% two weeks ago, thus making it expensive to short the stock, and making it ripe for a short squeeze.
Options activities have similarly exploded, with over 271,000 contracts being traded on June 24 alone, with 80.97% being calls, fueling speculation that market makers could be forced to hedge by buying shares, something known as a &#8220;gamma squeeze.&#8221;
There&#8217;s also been a lot of chatter surrounding BigBear.ai&#8217;s potential short squeeze in popular Reddit communities, and this has been going on for the past several months.
<figure class="wp-block-image aligncenter size-large is-resized"><img loading="lazy" decoding="async" width="977" height="1024" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25055128/Screenshot-2025-06-25-at-3.19.32-PM-977x1024.png" alt="" class="wp-image-961282" style="width:513px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25055128/Screenshot-2025-06-25-at-3.19.32-PM-977x1024.png 977w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25055128/Screenshot-2025-06-25-at-3.19.32-PM-286x300.png 286w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25055128/Screenshot-2025-06-25-at-3.19.32-PM-768x805.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25055128/Screenshot-2025-06-25-at-3.19.32-PM-1465x1536.png 1465w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25055128/Screenshot-2025-06-25-at-3.19.32-PM.png 1482w" sizes="(max-width: 977px) 100vw, 977px" /></figure>
<figure class="wp-block-image aligncenter size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="309" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25055145/Screenshot-2025-06-25-at-3.21.03-PM-1024x309.png" alt="" class="wp-image-961284" style="width:524px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25055145/Screenshot-2025-06-25-at-3.21.03-PM-1024x309.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25055145/Screenshot-2025-06-25-at-3.21.03-PM-300x90.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25055145/Screenshot-2025-06-25-at-3.21.03-PM-768x232.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25055145/Screenshot-2025-06-25-at-3.21.03-PM.png 1472w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
This was from the /r/ShortSqueeze community <a href="https://www.reddit.com/r/Shortsqueeze/comments/1g3bs3w/bbai_is_simple_short_squeeze_very_possible_if_not/">on</a> Reddit, with several other subreddits now actively discussing the stock, and its potential short squeeze over the next couple of days.
Why It Matters: Analysts maintain a <a href="https://www.benzinga.com/quote/BBAI/analyst-ratings">cautiously optimistic</a> outlook on the stock, with a consensus price target at $4.63 per share, 11.47% below its current levels.
According to The Motley Fool, BigBear is <a href="https://www.benzinga.com/markets/small-cap/25/06/45857163/the-next-palantir-does-this-under-5-ai-stock-have-the-potential-to-rise-and-shine">expected to underperform</a> for the next five years, since 40% of its revenue is tied to government contracts, which are now under threat as part of DOGE-related cutbacks. 
The company continues to disappoint on earnings, with $34.76 million in revenue <a href="https://www.benzinga.com/news/earnings/25/05/45152870/bigbear-ai-shares-slide-after-worse-than-expected-q1-report">during its first quarter</a>, missing estimates at $36.26 million, along with a loss of $0.26 per share, higher than estimates at $0.06 per share.
Price Action: Shares of BigBear.ai were up 25.12% on Tuesday, at $5.23, and are up a further 5.05% after hours, at the time of writing this.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="143" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25060237/Screenshot-2025-06-25-at-3.32.25-PM-1024x143.png" alt="" class="wp-image-961302" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25060237/Screenshot-2025-06-25-at-3.32.25-PM-1024x143.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25060237/Screenshot-2025-06-25-at-3.32.25-PM-300x42.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25060237/Screenshot-2025-06-25-at-3.32.25-PM-768x108.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25060237/Screenshot-2025-06-25-at-3.32.25-PM.png 1514w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
The stock scores high on momentum, at the 98th percentile, and has a favorable price trend in the short, medium and long terms. Click <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">here</a> for deeper insights into the stock. 
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/46089330/bernie-sanders-slams-job-cuts-says-ai-should-give-workers-more-time-off-instead-of-throwing-you-out-on-the-street">Bernie Sanders Slams Job Cuts, Says AI Should Give Workers More Time Off: &#8216;Instead Of Throwing You Out On The Street&#8230;&#8217;</a></li>
</ul>
Photo courtesy: PJ McDonnell / Shutterstock.com

BBAI

BigBear.ai's Surges Over 25% Amid Defense Contracts, Airport Deployments And Short Squeeze Hype

Macro Economic Events

Econ #s

Economics

France Jobseekers Total For May 3,002.0K Vs. 3,013.0K Prior

Repurchased $225 million principal amount of convertible notes removing approximately 8.3 million underlying shares as well as approximately $63.8 million of remaining interest
Issued 9.45 million shares to participating note holders to fund the repurchase
AST SpaceMobile, Inc. ("AST SpaceMobile") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, and designed for both commercial and government applications, today announced the pricing of a cash repurchase (the "Repurchase") of $225 million aggregate principal amount of its 4.25% convertible notes due 2032 (the "2032 convertible notes") pursuant to separate, privately negotiated repurchase transactions with a limited number of holders of the 2032 convertible notes and a registered direct offering of 9,450,268 shares of its Class A common stock to holders of 2032 convertible notes participating in the Repurchase in a direct placement registered under the Securities Act of 1933, as amended (the "Registered Direct Offering").
With this series of transactions, AST SpaceMobile, Inc. will issue approximately 1.04 million incremental shares to the underlying shares of the 2032 convertible notes being repurchased while removing $225 million of debt from the balance sheet and approximately $63.8 million of remaining interest. Both the closing of the Repurchase and the Registered Direct Offering are expected to take place on or about July 1, 2025. The transactions are cross-conditional.

ASTS

AST SpaceMobile Prices Cash Repurchase Of $225M Aggregate Principal Amount Of 4.25% Convertible Notes Due 2032

HC Wainwright &amp; Co. analyst Kevin Dede initiates coverage on CoreWeave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) with a Neutral rating.

Initiation

CRWV

HC Wainwright & Co. Initiates Coverage On CoreWeave with Neutral Rating

AKAM

Akamai Expands API Security With Managed Service, Code Scanning, Compliance Dashboard Amid Rising Threats And Industry Awards

HC Wainwright &amp; Co. analyst Mitchell Kapoor downgrades Sarepta Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) from Neutral to Sell and lowers the price target from $40 to $10.

Downgrades

SRPT

HC Wainwright & Co. Downgrades Sarepta Therapeutics to Sell, Lowers Price Target to $10

HC Wainwright &amp; Co. analyst Heiko Ihle reiterates U.S. Gold (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USAU#NASDAQ">USAU</a>) with a Buy and maintains $15 price target.

USAU

HC Wainwright & Co. Reiterates Buy on U.S. Gold, Maintains $15 Price Target

HC Wainwright &amp; Co. analyst Scott Buck reiterates Transcat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNS#NASDAQ">TRNS</a>) with a Buy and maintains $116 price target.

TRNS

HC Wainwright & Co. Reiterates Buy on Transcat, Maintains $116 Price Target

Rocket Lab Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) announced Wednesday that the European Space Agency (ESA) chose it to <a href="https://www.benzinga.com/pressreleases/25/06/b46089628/rocket-lab-to-launch-electron-mission-for-european-space-agencys-next-generation-navigation-system">launch a dedicated Electron mission</a> for the first time, marking a key step in Europe&#8217;s future LEO-based navigation system.
Rocket Lab will launch two &#8220;Pathfinder A&#8221; satellites, developed by Thales Alenia Space and GMV, from its Launch Complex 1 by December 2025. 
These satellites will enter a 510km low Earth orbit to test LEO-PNT (Low Earth Orbit Positioning, Navigation, and Timing), a new method for delivering location and timing services.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/06/45901809/rocket-lab-launches-fourth-mission-for-japans-iqps" rel="noreferrer noopener">Rocket Lab Launches Fourth Mission For Japan&#8217;s iQPS</a>
ESA aims to evaluate how satellites in low Earth orbit can complement the existing Galileo and EGNOS systems in medium and geostationary orbits.
Rocket Lab previously supported European clients, including a whole IoT constellation for Kinéis and a wildfire detection satellite for OroraTech. Its Electron vehicle began flying European missions in 2021.
In a separate update, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/b46083542/rocket-lab-executes-responsive-reschedule-of-electron-manifest-to-launch-next-mission-in-two-days-" rel="noreferrer noopener">the company announced</a> a rapid turnaround in its Electron launch schedule. It is preparing to launch its next mission for geospatial analytics firm HawkEye 360 in just two days from Launch Complex 1 in New Zealand.
Scheduled for no earlier than Thursday, June 26 UTC, the mission, titled &#8216;Get The Hawk Outta Here&#8217;, will fly ahead of a previously planned launch that was delayed for additional system checks. This swift pivot demonstrates Rocket Lab&#8217;s agility in maintaining a demanding, back-to-back launch cadence.
The mission will carry four satellites for HawkEye 360, including three microsats under Cluster 12 to geolocate global radio frequency signals, and Kestrel-0A, an experimental satellite to test future RF capabilities.
As the third of four planned Electron launches from Launch Complex 1 this month, the mission highlights Rocket Lab&#8217;s operational flexibility and commitment to serving diverse small satellite missions.
Rocket Lab stock surged 606% in the last 12 months. The company <a target="_blank" href="https://www.benzinga.com/markets/tech/25/06/45981509/rocket-labs-next-launch-in-4-days-is-rklb-ready-for-liftoff" rel="noreferrer noopener">just&nbsp;added&nbsp;two</a> new missions to its 2025 Electron launch manifest.
Rocket Lab has now secured a demand for over 20 launches in 2025. With a flawless mission success rate so far this year, CEO&nbsp;Peter Beck&nbsp;is betting big on scaling launch cadence.
Multiple analysts lifted price targets on Rocket Lab following <a target="_blank" href="https://www.benzinga.com/news/space/25/06/46002335/rocket-lab-stock-is-on-investor-radars-whats-going-on" rel="noreferrer noopener">the company&#8217;s acquisition</a> of high-performance optical systems&nbsp;producer Geost.
Rocket Lab said the acquisition positioned the company as a provider of end-to-end national security space solutions and strengthened its position for achieving the U.S. Department of Defense&#8217;s goals for resilient, proliferated space architectures, like the proposed&nbsp;Golden Dome architecture.
Price Action: RKLB shares are trading lower by 1.46% to $32.97 premarket at last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/06/46090054/why-blackberry-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket">Why BlackBerry Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket</a></li>
</ul>
Photo by Emagnetic via Shutterstock

RKLB

Europe's Navigation Future Takes Flight With Rocket Lab Electron

Elon Musk's commercial space exploration company SpaceX launched its new Dragon spacecraft on its debut as part of <a href="https://www.benzinga.com/news/space/25/06/45943559/spacex-ax-4-launch-set-after-june-19-following-propellant-leak-delay">the Ax-4 mission</a> to the International Space Station on Tuesday.
However, the mission is also significant for India as the mission marks the first time in over 40 years that an Indian astronaut has been sent to space since 1984's Soviet Interkosmos mission, which took Indian Air Force Officer and Astronaut Rakesh Sharma to space.
Indian Astronaut Shubhanshu Shukla is a part of the 4-person crew, led by Axiom Space's Director of Human Spaceflight Peggy Whitson. The crew also includes Sławosz Uznański-Wiśniewski and Tibor Kapu. The mission comes in despite Musk's calls to <a href="https://www.benzinga.com/news/space/25/06/45923417/elon-musk-sounds-alarm-over-international-space-station-says-it-should-be-de-orbited-within-2-years">deorbit the International Space Station</a> over safety concerns.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Falcon 9 launches Ax-4, Dragon's 18th human spaceflight mission <a href="https://t.co/gVnDUJFrvH">pic.twitter.com/gVnDUJFrvH</a>
&mdash; SpaceX (@SpaceX) <a href="https://twitter.com/SpaceX/status/1937803691047952437?ref_src=twsrc%5Etfw">June 25, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The crew will spend over two weeks at the ISS before coming back down to Earth after conducting over 60 experiments in Space. The mission was originally supposed to launch on June 12, but a propellant leak forced SpaceX and Axiom Space to <a href="https://www.benzinga.com/news/space/25/06/45878837/spacexs-ax-4-astronaut-mission-to-iss-delayed-over-propellant-leak-new-launch-date-yet-to-be-announced">delay the launch</a>.
A Look Back At India's Space Ventures
India has had an active space program for a while, with the country's Space Agency, ISRO, or Indian Space Research Organization, having conducted multiple successful space missions.
The country launched the Chandrayaan-1, the country's maiden lunar probe, in 2008. It was the first Spacecraft developed entirely by the country. It was inserted into the lunar orbit on November 8, 2008. ISRO launched Chandrayaan-2, which crashed on the lunar surface in 2019, as well as Chandrayaan-3, which landed on the Moon's surface in 2023.
Besides this, the country also launched the Mars Orbiter Mission, where ISRO launched its first probe towards the planet Mars in 2013. The probe has been orbiting the Red Planet since 2014, and the agency lost contact with the probe in April 2022.
The mission was India's first interplanetary spaceflight and made ISRO only the fourth Agency to send a rover to Mars.
The country also plans on launching its first-ever human space flight vehicle, the Gaganyaan-1. The spacecraft is slated to launch in 2027 and will serve as the basis of ISRO's Human Space Flight Programme.
Check out more of Benzinga's Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/space/25/06/46012079/elon-musks-spacex-suffers-major-setback-as-starship-rocket-explodes-in-static-fire-test">Elon Musk&#8217;s SpaceX Suffers Major Setback As Starship Rocket Explodes In Static Fire Test</a></li>
</ul>
Photo courtesy: Shutterstock

SPACE

India May Have Been To Mars And Moon, But An Indian Hasn't Been In Space For 41 Years: Elon Musk Just Changed That

Mike Gallagher, Head of Defense at Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>), said Iran&#8217;s nuclear program has been &#8220;set back significantly&#8221; following weekend U.S. military strikes on three Iranian nuclear facilities, though intelligence assessments remain conflicted over the operation&#8217;s long-term impact.
What Happened: Speaking <a href="https://www.cnbc.com/video/2025/06/24/palantirs-mike-gallagher-enforcing-a-ceasefire-will-require-a-greater-investment-of-american-power.html">on</a> CNBC, Gallagher cited early reports indicating substantial damage to Iran&#8217;s nuclear infrastructure. &#8220;The early reports indicate we&#8217;ve set back the program significantly,&#8221; said Gallagher, a former Wisconsin congressman who joined Palantir as its defense chief.
The assessment comes amid <a href="https://www.benzinga.com/news/25/06/46086403/us-attack-on-iranian-nuclear-sites-reportedly-set-tehran-back-only-a-few-months-white-house-calls-assessment-flat-out-wrong">conflicting intelligence reports</a> about Operation Midnight Hammer&#8217;s effectiveness. While the White House maintains the strikes were an &#8220;overwhelming success,&#8221; a Defense Intelligence Agency assessment suggests the damage may only delay Iran&#8217;s nuclear ambitions by &#8220;a few months, tops,&#8221; according to sources cited by CNN.
Seven B-2 stealth bombers from Northrop Grumman Corp. <a href="https://www.benzinga.com/markets/equities/25/06/46045651/northrop-grumman-jumps-5-overnight-as-b-2-bombers-return-to-missouri-after-36-hour-iran-strike-trump-says-job-well-done">conducted the 36-hour mission</a> targeting facilities at Fordow, Natanz, and Isfahan. The operation involved over 125 aircraft and guided missile submarines in what Gallagher described as demonstrating capabilities &#8220;no other country in the world&#8221; possesses.
Gallagher emphasized the strikes&#8217; broader deterrent effect, particularly regarding China. &#8220;I do think this has had a positive effect on deterrence in Indo-Pacific Command,&#8221; he said, drawing parallels to similar dynamics during Trump&#8217;s first administration.
See Also: <a href="https://www.benzinga.com/news/politics/25/06/46087359/zohran-mamdani-leads-nyc-mayoral-primary-andrew-cuomo-concedes-race">Zohran Mamdani Leads NYC Mayoral Primary, Andrew Cuomo Concedes Race: &#8216;He Deserved It. He Won&#8217;</a>
Why It Matters: The former congressman noted that Iran&#8217;s enriched uranium stockpile reportedly remained intact, having been moved before the strikes. However, he highlighted the loss of Iranian nuclear scientists, stating Israel allegedly eliminated eight of 13 top Iranian nuclear experts, making program reconstruction more difficult.
President Donald Trump announced a ceasefire between Israel and Iran on Monday, though reports of renewed hostilities <a href="https://www.benzinga.com/news/events/25/06/46068524/israel-says-iran-broke-trump-ceasefire-orders-high-intensity-strikes-on-tehran">have raised durability concerns</a>. 
Palantir shares have surged 483% over 12 months, with the company <a href="https://www.benzinga.com/markets/equities/25/06/45988762/palantir-rejects-surveillance-claims-after-being-compared-to-nazi-collaborators-touts-pltrs-transparent-lineage">securing over $113 million in new federal contracts</a> since Trump&#8217;s inauguration, including a $795 million Defense Department agreement.
According to&nbsp;Benzinga's Edge Stock Rankings, Palantir shows strong Short-, Medium-, and Long-Term Price Trends. Here's&nbsp;<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound" target="_blank" rel="noreferrer noopener">how the stock performs across other key metrics</a>. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound" target="_blank" rel="noreferrer noopener"></a>
<figure class="wp-block-image aligncenter size-full is-resized"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="890" height="644" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25053305/image-374.png" alt="" class="wp-image-961246" style="width:449px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25053305/image-374.png 890w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25053305/image-374-300x217.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25053305/image-374-768x556.png 768w" sizes="(max-width: 890px) 100vw, 890px" /></a></figure>
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/46089330/bernie-sanders-slams-job-cuts-says-ai-should-give-workers-more-time-off-instead-of-throwing-you-out-on-the-street">Bernie Sanders Slams Job Cuts, Says AI Should Give Workers More Time Off: &#8216;Instead Of Throwing You Out On The Street&#8230;&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: slyellow / Shutterstock.com

Palantir's Defense Chief Says Iran Nuclear Program 'Set Back Significantly' By US Strikes—But Intel Split On How Long

On Tuesday, June 24, U.S. markets closed higher as investors responded positively to a ceasefire between Israel and Iran and awaited signals from the Federal Reserve. The Nasdaq 100 reached a record close, and the S&amp;P 500 neared its previous peak.
Tech shares led the rally, while energy stocks slipped on lower oil prices. Fed Chair Powell emphasized a cautious approach to rate cuts, with weakening consumer confidence adding to expectations for future easing.
In economic data, the U.S. current account deficit jumped 44% to $450.2 billion in Q1, above the prior $312 billion and slightly above forecasts. Meanwhile, home price growth slowed, with the S&amp;P Case-Shiller Index rising 3.4% in April, down from 4.1% in March.
Most S&amp;P 500 sectors ended higher on Tuesday, led by tech, communication services, and financials. Energy stocks declined, bucking the trend.
The Dow rose 1.19% to 43,089.02, the S&amp;P 500 was up 1.11% to 6,092.18, and the Nasdaq gained 1.43% to 19,912.53.
<h2 class="wp-block-heading">Asia Markets Today</h2>
On Wednesday, Japan&#8217;s Nikkei 225 closed 0.40% higher at 38,946.00, led by gains in the Real Estate, Banking, and Textile sectors.
Australia&#8217;s S&amp;P/ASX 200 was up 0.04% at 8,559.20, led by gains in the Financials, Consumer Discretionary and Utilities sectors.
India&#8217;s Nifty 50 was up 0.80% at 25,244.05, and the Nifty 500 gained 0.79% to 23,295.80.
China&#8217;s Shanghai Composite was up 1.01% at 3,455.97, and Shanghai Shenzhen CSI 300 rose 1.44% to 3,960.07.
Hong Kong&#8217;s Hang Seng closed the session 1.23% higher at 24,474.67.
<h2 class="wp-block-heading">Eurozone at 05:45 AM ET</h2>
The European STOXX 50 index was down 0.13%.
Germany&#8217;s DAX index declined 0.33%.
France&#8217;s CAC 40 slid 0.06%.
U.K.&#8217;s FTSE 100 index traded lower by 0.01%.
<h2 class="wp-block-heading">Commodities at 05:45 AM ET</h2>
Crude Oil WTI was trading higher by 1.27% at $65.19/bbl, and Brent was up 1.12% at $66.92/bbl.
Oil prices rose over 1% as U.S. demand remained firm, and a fragile ceasefire eased supply fears. Expectations of Fed rate cuts also supported the market&#8217;s demand outlook.
Natural gas fell 0.03% to $3.654.
Gold traded higher by 0.11% to $3,337.12, Silver slid 0.21% to $35.658, and Copper gained 0.24% to $4.8840.
Gold prices inched higher Wednesday as a weaker dollar offered support, offsetting pressure from easing geopolitical tensions after the Israel-Iran ceasefire. Other metals also rose slightly on a softer dollar.
<h2 class="wp-block-heading">U.S. Futures</h2>
At 05:45 AM ET, the Dow Jones futures fell 0.07%, the S&amp;P 500 declined 0.02%, and the Nasdaq 100 was up 0.06%.
<h2 class="wp-block-heading">Forex</h2>
At 05:45 AM ET, the U.S. Dollar Index gained 0.12% to 98.10, USD/JPY was up 0.50% to 145.66, and USD/AUD slid 0.08% to 1.5398.
The dollar hovered near a four-year low against the euro as easing oil prices and a shaky Middle East truce reduced inflation fears, boosting rate-cut hopes and risk appetite.
Photo via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia Up, Europe Markets Slip, Dollar Under Pressure On Increased Risk Appetite - Global Markets Today While US Slept

U.S. futures were flat on Wednesday after a positive day of trading on Tuesday. Futures of major benchmark indices were slightly positive.
Investors hoped the ceasefire between Iran and Israel would hold and help calm geopolitical tensions. President Donald Trump declared Tuesday that a ceasefire between the two adversaries was back in effect, even as reports of renewed hostilities raised doubts about its durability.
&#8220;Israel is not going to attack Iran. All planes will turn around and head home, while doing a friendly ‘Plane Wave&#8217; to Iran,&#8221; Trump posted on Truth Social, adding, &#8220;<a href="https://www.benzinga.com/news/politics/25/06/46072859/trump-says-israel-is-not-going-to-attack-iran-after-ceasefire-violation-turn-around-and-head-home">the Ceasefire is in effect!</a>&#8220;
The 10-year Treasury bond yielded 4.29% and the two-year bond was at 3.79%. The CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>&#8216;s projections show markets pricing a 79,3% likelihood of the Federal Reserve keeping the current interest rates unchanged in its July meeting. 
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.01%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.06%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>0.10%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.11%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were higher in premarket on Tuesday. The SPY was up 0.069% at $607.20, while the QQQ advanced 0.14% to $540.51, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From Last Session:
Information technology, communication services, and financial stocks led the gains on Tuesday, propelling U.S. stocks higher, with the Dow Jones index climbing over 500 points.
However, energy stocks bucked the overall market trend, closing the session lower.
Separately, TD Synnex Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNX#NYSE">SNX</a>) reported better-than-expected earnings for the second quarter, and Nano Labs Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NA#NASDAQ">NA</a>) shares surged 36% after announcing a $500 million convertible notes private placement for its BNB treasury strategy.
On the economic front, the U.S. current account deficit widened by 44.3% to $450.2 billion in the first quarter, exceeding market estimates, while the S&amp;P CoreLogic Case-Shiller Home Price Index saw a smaller 3.4% year-over-year increase in April.
The Dow Jones index ended 507 points or 1.19% higher at 43,089.02, whereas the S&amp;P 500 index rose 1.11% to 6,092.18. Nasdaq Composite advanced 1.43% to 19,912.53, and the small-cap gauge, Russell 2000, gained 1.34% to end at 2,161.21.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>1.43%</td>
<td>19,912.53</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>1.11%</td>
<td>6,092.18</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>1.19%</td>
<td>43,089.02</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1.34%</td>
<td>2,161.21</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
Jurrien Timmer of Fidelity Investments said in a series of X posts that the S&amp;P 500 index was rangebound as it flirts with the all-time high and is heavily dependent on the movement of the Magnificent 7 stocks.
&#8220;The correction this year held at the 2021 high, and so far the recovery has been bounded by the 2025 high. That seems like a reasonable range to me,&#8221; he said.
He also predicted that the 20% &#8216;V&#8217; shaped recovery in the index from April lows could turn &#8220;to an M from here.&#8221; He pointed out that &#8220;there are only a few historical analogs left in which the market continues to make new highs so soon after drawing down 20%.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The V-shaped recovery in April has brought the S&amp;P 500 index back to within 2% of its all-time highs, while the MSCI EAFE index is making consistent new highs. As the chart shows below, there are only a few historical analogs left in which the market continues to make new highs… <a href="https://t.co/Fu0E5Z4MQJ">pic.twitter.com/Fu0E5Z4MQJ</a>
&mdash; Jurrien Timmer (@TimmerFidelity) <a href="https://twitter.com/TimmerFidelity/status/1937511169318637675?ref_src=twsrc%5Etfw">June 24, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Talking about the market breadth, he highlighted that the market has narrowed again, with only half of the stocks in the S&amp;P 500 trading above their various moving averages.
Meanwhile, he said the Magnificent 7, which led the downside in March and April, has led the upside in May but remains below its all-time high set in December. &#8220;Given the degree of concentration of these companies, wherever the Mag 7 goes, so goes the index as a whole.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The Mag 7, which led the downside in March and April, has led the upside in May but remains below its all-time high set in December. Given the degree of concentration of these companies, wherever the Mag 7 goes, so goes the index as a whole. <a href="https://t.co/0tvvI9y4aZ">pic.twitter.com/0tvvI9y4aZ</a>
&mdash; Jurrien Timmer (@TimmerFidelity) <a href="https://twitter.com/TimmerFidelity/status/1937512081429004339?ref_src=twsrc%5Etfw">June 24, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Talking about the ongoing tensions in the Middle East, Ed Yardeni said, &#8220;Any day with a ceasefire in the Middle East is a good day for stocks.&#8221;
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures </a>
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on Wednesday:
<ul class="wp-block-list">
<li>May&#8217;s new home sales will be released at 10:00 a.m. ET.</li>
</ul>
Stocks In Focus:
<ul class="wp-block-list">
<li>General Mills Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>) was up 0.094% in premarket on Wednesday as analysts expect it to report quarterly earnings of 71 cents per share on revenue of $4.59 billion, before the opening bell.</li>
<li>Paychex Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) advanced 0.27% as analysts expect it to report quarterly earnings of $1.19 per share on revenue of $1.42 billion, before the opening bell.</li>
<li>Micron Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) was 0.657% higher as analysts expect it to report quarterly earnings of $1.59 per share on revenue of $8.86 billion after the closing bell.</li>
<li>Winnebago Industries Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WGO#NYSE">WGO</a>) fell 0.13% as analysts expect it to report quarterly earnings of 79 cents per share on revenue of $774.81 million, before the opening bell.</li>
<li>AeroVironment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>) rose 1.41% after upbeat results. It sees fiscal 2027 adjusted EPS in a range of $2.80 to $3, versus the $3.72 estimate, and revenue in a range of $1.9 billion to $2 billion, versus the $1.98 billion estimate.</li>
<li>Worthington Enterprises Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOR#NYSE">WOR</a>) jumped 11.39% after reporting better-than-expected fourth-quarter financial results. The company reported quarterly earnings of $1.06 per share, which beat the analyst consensus estimate of 84 cents per share.</li>
<li>Robinhood Markets Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) gained 2.98% as it is set to release its month-to-date trading metrics for June this Thursday, according to an update on the company's investor relations website.</li>
<li>Quantumscape Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QS#NYSE">QS</a>) surged 30.25% after its Cobra separator process entered into baseline production.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading higher in the early New York session by 0.87% to hover around $64.93 per barrel.
Gold Spot US Dollar rose 0.03% to hover around $3,323.71 per ounce. Its last record high stood at $3,500.33 per ounce. The U.S. Dollar Index spot was higher by 0.24% at the 98.0900 level.
Asian markets ended higher on Wednesday as Australia's ASX 200, Japan's Nikkei 225, China&#8217;s CSI 300, South Korea's Kospi, Hong Kong's Hang Seng, and India's S&amp;P BSE Sensex indices advanced. European markets were mixed in early trade.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/46068345/blackrock-bets-big-on-defense-companies-amid-escalating-geopolitical-tensions-palantir-lockheed-martin-northrop-grumman-among-stocks-in-focus">BlackRock Bets Big On Defense Companies Amid Escalating Geopolitical Tensions: Palantir, Lockheed Martin, Northrop Grumman Among Stocks In Focus</a></li>
</ul>
Photo courtesy: godongphoto / Shutterstock.com

AVAV

HOOD

PAYX

US Stocks Likely To Edge Higher As Iran-Israel Ceasefire Holds: Micron Technology, General Mills In Focus Ahead Of Earnings

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.nextracker.com&amp;esheet=54281976&amp;newsitemid=20250625294414&amp;lan=en-US&amp;anchor=Nextracker&amp;index=1&amp;md5=d56bf7d0927a01a730bc75f096b338bb">Nextracker</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXT#NASDAQ">NXT</a>), a global leader in advanced solar energy solutions, today announced that its <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.nextracker.com%2Fnx-horizon-solar-tracker&amp;esheet=54281976&amp;newsitemid=20250625294414&amp;lan=en-US&amp;anchor=NX+Horizon%26%238482%3B+solar+trackers&amp;index=2&amp;md5=3347a71a5bda74ca84c681ebf8da5af1">NX Horizon&#x2122; solar trackers</a> will power one of Europe's largest solar projects, the 550 MW "Oricheio PPC Ptolemaida" solar PV park in Western Macedonia. Owned by Greek PPC Renewables (PPCR), a wholly owned subsidiary of utility PPC Group, the project was constructed by engineering procurement and construction (EPC) company Terna SA by repurposing the land of a former coal mine with high-performance solar energy infrastructure to generate clean, lower-cost electricity. Now in its final stage of construction, Oricheio PPC Ptolemaida is the largest single solar power project in Greece and is estimated to provide nearly 1.8% of the country's electricity per year when fully operational.

Nextracker To Power One of Europe's Largest Solar Projects on Former Greek Coal Mine

<ul>
<li>The BRUKINSA tablets have been shown to be bioequivalent to the BRUKINSA capsules based on the results of two single-dose, open-label, randomized Phase 1 crossover studies in healthy subjects. The recommended dose of BRUKINSA remains – 320 mg daily. The BRUKINSA tablets are 160 mg each, allowing patients to halve their daily pill intake and take two tablets daily. The new tablet formulation maintains BRUKINSA's dosing flexibility by providing patients and prescribers with the option of once- or twice-daily dosing and is designed to simplify management of dose reductions as per label recommendation. Additionally, the BRUKINSA tablets are smaller than the capsules and have a film coat, which makes them easier to swallow.</li>
<li>Today's announcement follows the U.S. Food and Drug Administration (FDA) approval of the new tablet formulation of BRUKINSA for all five approved indications earlier this month. In the U.S., BRUKINSA is the leader in new patient starts for chronic lymphocytic leukemia (CLL) across all lines of therapy, and for the first time, has become the overall BTK inhibitor market share leader.1</li>
</ul>

Large Cap

The Committee For Medicinal Products For Human Use Of The European Medicines Agency Issued A Positive Opinion Recommending Approving A New Film-coated Tablet Formulation Of BeOne Medicines' Brukinsa (Zanubrutinib) For All Approved Indications

STEC

Santech Holdings Says Total Revenues From Continuing Operations For The Six Months Ended December 31, 2024 Decreased To Nil From $17.4M YoY

<a href="https://www.globenewswire.com/Tracker?data=HDtEWk54r0OhSPTmZxzQhbihFXVAOlDizQAhsLAWmZdn2-lk-VUNETADvgCvTbAVW937XGiLG2tCvT6l4gH_Ow==">Aclarion, Inc</a>., ("Aclarion" or the "Company") (NASDAQ:<a href="https://www.benzinga.com/stock/ACON#NASDAQ">ACON</a>, ACONW)), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced the first patient enrollment in the CLARITY (Chronic&nbsp;Low bAck pain&nbsp;Randomized&nbsp;Independent&nbsp;Trial studY) trial evaluating Nociscan's clinical and economic value in spine surgery. The first patient was enrolled at the <a href="https://www.globenewswire.com/Tracker?data=Jy7d2HXHTb7E0LCHvjAOQNLpsrVak3ysKve7MEj1rLhSk7oTy5l-Uik_asg6cqZgXtcWfnlj3a36isxhzNvwDKu3wQn3o13eKnTWsZMGJNE=">Texas Back Institute</a>.
"Texas Back Institute has a long history of advancing spine care through clinical trial research," said Alexander Satin, MD, board-certified orthopedic spine surgeon and principal investigator for the CLARITY trial. "We have followed the advancements from Aclarion and their Nociscan platform.&nbsp;The CLARITY trial will allow us to observe patient-specific critical pain biomarker data and the relationship with surgical outcomes. Our physicians and research leaders have extensive experience treating patients with chronic low back pain and we are pleased to participate in this important trial, including enrollment of the first patient."
The CLARITY trial is a prospective, randomized multi-center study evaluating patients who are scheduled to undergo surgical treatment of 1- or 2- level discogenic low back pain. The study will enroll 300 patients at multiple high-volume sites across the US and all patients will receive a Nociscan prior to surgery. The study will be randomized at a 1:1 ratio of surgeons blinded-to-Nociscan and unblinded-to-Nociscan to guide the surgical treatment (Fusion / TDR). The primary endpoint is change in back pain as measured on a 100mm VAS Back at 12 months compared to baseline, with several secondary endpoints collected. The principal investigator for the trial is Dr. Nicholas Theodore of Johns Hopkins Medicine. Other sites that have been activated include Northwestern Medicine, Advocate Aurora Research Institute, Keck Medicine at USC and UHealth - University of Miami Health System and University of Miami Miller School of Medicine.
Chronic low back pain is a global healthcare problem with approximately 266 million people worldwide suffering from degenerative spine disease and low back pain. Aclarion's Nociscan solution is the first evidence-supported SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Nociscan objectively quantifies chemical biomarkers demonstrated to be associated with disc pain and has the potential to drive better surgical outcomes.

ACON

Aclarion Launches Major US Trial to Test AI Tool That Could Improve Spine Surgery for Chronic Back Pain

Press Releases

CBAK Partners with Kandi to Localize Lithium Battery Facilities in the U.S. in Phases

CBAK Energy Captures 14.6% Share of 32140 Cylindrical Cell Market in Q1 2025

CBAK Energy to Participate in Shenzhen International Battery Technology Conference & Expo on Tuesday, May 15, 2025

CBAK Energy to Report First Quarter 2025 Unaudited Financial Results on Monday, May 19, 2025

Earnings

CBAK Energy Reports First Quater 2025 Unaudited Financial Results

CBAK Energy to Participate in The Battery Show Europe on June 3, 2025

CBAK Energy Launches Share Buyback Program Authorizing Repurchase of Up to $20 Million in Common Stock Over the Next 12 Months

Contracts

CBAK Energy Secures $3 Million Follow-up Order from Livguard, Strengthening Strategic Partnership in India

CBAK Energy Announces $11.6 Million Order from Africa's largest EV player

CBAK Energy Engages FAW, one of China's largest EV makers, in Strategic Talks on New EV Battery Model 46950

CBAT

Amprius Technologies

Asia Pacific Wire & Cable Corporation Limited - Common shares, Par value .01 per share

Comments

CBAK Energy Tech

Notizie

Ultime notizie per CBAK Energy Tech (NASDAQ:CBAT) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO